Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world today, contributing to surging rates of cardiovascular disease, fatty liver disease, kidney complications and ballooning healthcare expenses. What once represented a specialized class of diabetes... The post Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities appeared first on Montreal Gazette .

Original source: Montreal Gazette